FAQs

FREQUENTLY ASKED QUESTIONS

syncromune was incorporated in 2020.

syncromune is headquartered in Fort Lauderdale, FL

syncromune is a corporation under the laws of the state of Delaware.

syncromune's fiscal year end is December 31.

If you are interested in purchasing shares of syncromune, inc. please contact:

Joseph Gerardi

Chief Financial Officer

Email: jgerardi@syncromune.com

syncromune is a private company and does not currently have a transfer agent.

as a private company, syncromune does not currently publish public quarterly earnings reports. If you are interested in learning more about our corporate and clinical development programs, please contact:

Joseph Gerardi

Chief Financial Officer

Email: jgerardi@syncromune.com

members of the syncromune leadership team can be found here.

For syncromune investor relations, please contact:

Danielle Hobbs

EVP, Investor Relations & Corporate Communications

Email: investors@syncromune.com

For syncromune media relations, please contact:

Danielle Hobbs

EVP, Investor Relations & Corporate Communications

Email: media@syncromune.com

press releases can be found on the investors & media page, located here.

upcoming events can be found here.

information about our target cancers can be found here.

for further questions, please contact:

Joseph Gerardi

Chief Financial Officer

Email: jgerardi@syncromune.com

Contact Information

Danielle Hobbs

EVP, Investor Relations & Corporate Communications

Social Media

Disclaimer

The information contained in our press releases and presentations should be considered accurate only as of the date it was originally issued. Syncromune™ disavows any obligation to update the information contained in these press releases and presentations after the date of their issuance.